Skip to content

Biomakers

Tumor genomic testing labs across Latin America

Raised to date

$5.9M

of $8M offered across 1 Form D filing

Still open
$2.1M
Investors
7
Last filed
Apr 29, 2026

About

BIOMAKERS is a precision oncology company that runs genomic and molecular testing for cancer patients and combines the results with clinical data, biobanking, and AI on a single platform. It operates clinical laboratories in Argentina, Brazil, and Mexico serving a network of thousands of physicians across Latin America, and is headquartered in San Francisco, California. Testing spans immunohistochemistry, FISH, real-time and digital PCR, and next-generation sequencing, and the company reports hundreds of thousands of genomic studies completed and a biobank of tumor samples. Alongside patient diagnostics, it sells the resulting real-world genomic and clinical data to life sciences companies for drug and diagnostic development.

It pairs a Latin American clinical testing and biobanking footprint most global diagnostics companies do not have with an AI-native data layer, so the same infrastructure that returns a therapy recommendation to a treating physician also produces globally relevant real-world oncology data for drug developers.

Funding

  • EquityFiled Apr 29, 2026Form D/A
    $5.9M/ $8M

Product

BIOMAKERS precision oncology platform

Molecular diagnostics

Genomic and molecular tumor profiling delivered through the company's own clinical laboratories, with results integrated into a platform that connects testing, clinical data, and biobanked specimens to support targeted therapy decisions.

  • Next-generation sequencing, PCR, FISH, and immunohistochemistry tumor profiling
  • Company-operated clinical laboratories in Argentina, Brazil, and Mexico
  • Bioinformatics analysis producing targeted therapeutic recommendations

Built for

Oncologists and cancer patients in Latin America, plus life sciences companies buying real-world oncology data

People on file